APA (7th ed.) Citation

Kakani, P., Katcher, B. A., & Maini, L. (2025). Improved Insurance Coverage Increased Biosimilar Semglee's Market Share After The FDA's Interchangeability Designation. Health Affairs, 44(11), 1417. https://doi.org/10.1377/hlthaff.2025.00443

Chicago Style (17th ed.) Citation

Kakani, Pragya, Bradley A. Katcher, and Luca Maini. "Improved Insurance Coverage Increased Biosimilar Semglee's Market Share After The FDA's Interchangeability Designation." Health Affairs 44, no. 11 (2025): 1417. https://doi.org/10.1377/hlthaff.2025.00443.

MLA (9th ed.) Citation

Kakani, Pragya, et al. "Improved Insurance Coverage Increased Biosimilar Semglee's Market Share After The FDA's Interchangeability Designation." Health Affairs, vol. 44, no. 11, 2025, p. 1417, https://doi.org/10.1377/hlthaff.2025.00443.